首页 正文

Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study

{{output}}
Trastuzumab deruxtecan is a life-saving but costly therapy for HER2-positive cancers. While dose rounding strategies have been proposed to reduce drug waste, their safety and cost-saving potential in real-world Chinese patients remain understudied. This study ... ...